Your browser doesn't support javascript.
loading
Triple monoamine uptake inhibitors demonstrate a pharmacologic association between excessive drinking and impulsivity in high-alcohol-preferring (HAP) mice.
O'Tousa, David S; Warnock, Kaitlin T; Matson, Liana M; Namjoshi, Ojas A; Linn, Michael Van; Tiruveedhula, Veera Venkata; Halcomb, Meredith E; Cook, James; Grahame, Nicholas J; June, Harry L.
Afiliação
  • O'Tousa DS; Department of Psychology, Indiana University-Purdue University, Indianapolis, IN, USA.
Addict Biol ; 20(2): 236-47, 2015 Mar.
Article em En | MEDLINE | ID: mdl-24118509
ABSTRACT
Approximately 30% of current drinkers in the United States drink excessively, and are referred to as problem/hazardous drinkers. These individuals, who may not meet criteria for alcohol abuse or dependence, comprise binge, heavy drinkers, or both. Given their high prevalence, interventions that reduce the risk of binge and heavy drinking have important public health implications. Impulsivity has been repeatedly associated with excessive drinking in the clinical literature. As impulsivity is correlated with, and may play a critical role in, the initiation and maintenance of excessive drinking, this behavior may be an important target for therapeutic intervention. Hence, a better understanding of pharmacological treatments capable of attenuating excessive drinking and impulsivity may markedly improve clinical outcomes. The high-alcohol-preferring (HAP) mice represent a strong rodent model to study the relationship between impulsivity and excessive alcohol drinking, as recent evidence indicates they consume high levels of alcohol throughout their active cycle and are innately impulsive. Using this model, the present study demonstrates that the triple monoamine uptake inhibitors (TUIs) amitifadine and DOV 102, 677 effectively attenuate binge drinking, heavy drinking assessed via a 24-hour free-choice assay, and impulsivity measured by the delay discounting procedure. In contrast, 3-PBC, a GABA-A α1 preferring ligand with mixed agonist-antagonist properties, attenuates excessive drinking without affecting impulsivity. These findings suggest that in HAP mice, monoamine pathways may predominate as a common mechanism underlying impulsivity and excessive drinking, while the GABAergic system may be more salient in regulating excessive drinking. We further propose that TUIs such as amitifadine and DOV 102, 677 may be used to treat the co-occurrence of impulsivity and excessive drinking.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Aza / Comportamento Animal / Consumo de Bebidas Alcoólicas / Inibidores Seletivos de Recaptação de Serotonina / Inibidores da Captação de Dopamina / Inibidores da Captação Adrenérgica / Compostos Bicíclicos Heterocíclicos com Pontes / Consumo Excessivo de Bebidas Alcoólicas / Comportamento Impulsivo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos Aza / Comportamento Animal / Consumo de Bebidas Alcoólicas / Inibidores Seletivos de Recaptação de Serotonina / Inibidores da Captação de Dopamina / Inibidores da Captação Adrenérgica / Compostos Bicíclicos Heterocíclicos com Pontes / Consumo Excessivo de Bebidas Alcoólicas / Comportamento Impulsivo Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Addict Biol Assunto da revista: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos